Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
MIR448 antagomir reduces arrhythmic risk after myocardial infarction by upregulating the cardiac sodium channel
Gyeoung-Jin Kang, An Xie, Hong Liu, Samuel C. Dudley Jr.
Gyeoung-Jin Kang, An Xie, Hong Liu, Samuel C. Dudley Jr.
View: Text | PDF
Research Article Cardiology

MIR448 antagomir reduces arrhythmic risk after myocardial infarction by upregulating the cardiac sodium channel

  • Text
  • PDF
Abstract

Cardiac ischemia is associated with arrhythmias; however, effective therapies are currently limited. The cardiac voltage-gated sodium channel α subunit (SCN5A), encoding the Nav1.5 current, plays a key role in the cardiac electrical conduction and arrhythmic risk. Here, we show that hypoxia reduces Nav1.5 through effects on a miR, miR-448. miR-448 expression is increased in ischemic cardiomyopathy. miR-448 has a conserved binding site in 3′-UTR of SCN5A. miR-448 binding to this site suppressed SCN5A expression and sodium currents. Hypoxia-induced HIF-1α and NF-κB were major transcriptional regulators for MIR448. Moreover, hypoxia relieved MIR448 transcriptional suppression by RE1 silencing transcription factor. Therefore, miR-448 inhibition reduced arrhythmic risk after myocardial infarction. Here, we show that ischemia drove miR-448 expression, reduced Nav1.5 current, and increased arrhythmic risk. Arrhythmic risk was improved by preventing Nav1.5 downregulation, suggesting a new approach to antiarrhythmic therapy.

Authors

Gyeoung-Jin Kang, An Xie, Hong Liu, Samuel C. Dudley Jr.

×

Figure 7

Ischemia relieves RE1 silencing transcription factor repression of MIR448.

Options: View larger image (or click on image) Download as PowerPoint
Ischemia relieves RE1 silencing transcription factor repression of MIR44...
(A) Effect of REST gene silencing on the miR-448 level in CMs. Cells were transfected with control or RE1 silencing transcription factor (REST) siRNA for 24 hours. (B) Effect of REST gene silencing on the mRNA (top) and protein (bottom) level of SCN5A in CMs. Cells were transfected with control or REST siRNA for 24 hours. (C) Effect of X5050, a REST inhibitor, on the protein level of Nav1.5 in CMs. Cells were treated with X5050 for 24 hours. (D) Effect of hypoxic condition on the mRNA (top) and protein (bottom) level of REST. Cells were stimulated with DFX for 6 hours or were incubated with normoxia or hypoxia for 6 hours. (E) Diagram showing MIR448 transcriptional regulation by HIF-1α, NF-κB, and REST in normoxia and hypoxia. Data are represented as the mean + SD of 4 independent experiments. ***P < 0.001 (when compared between indicated groups by Student’s t test).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts